Insider · CIK 0001791040
Poggetto John Dal
Files at SNOA (Sonoma Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Poggetto John Dal files SEC Form 4 as officer at SNOA (Sonoma Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Poggetto John Dal has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | SNOA Sonoma Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +7,500 | $0.00 | $0 | 32,750 | Jul 9, 2026 |
| Jan 2, 2026 | SNOA Sonoma Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +5,000 | $0.00 | $0 | 25,250 | Jan 2, 2026 |
| Jun 19, 2025 | SNOA Sonoma Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +10,000 | $0.00 | $0 | 20,250 | Jun 20, 2025 |
| Jan 2, 2025 | SNOA Sonoma Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +7,500 | $0.00 | $0 | 10,250 | Jan 3, 2025 |
| Jun 20, 2024 | SNOA Sonoma Pharmaceuticals, Inc. | AGrant or award Common Stock, $0.0001 par value | +15,000 | - | - | 15,000 | Jun 21, 2024 |
| Dec 29, 2023 | SNOA Sonoma Pharmaceuticals, Inc. | AGrant or award Stock option (right to buy)derivative | +50,000 | - | - | 55,000 | Dec 29, 2023 |
Questions about Poggetto John Dal
Answered from the filings on this page, as of the latest one.
Is Poggetto John Dal buying or selling?
Poggetto John Dal has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Poggetto John Dal's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Poggetto John Dal has 0.
Where does Poggetto John Dal file Form 4?
Poggetto John Dal has filed Form 4 at SNOA (Sonoma Pharmaceuticals, Inc.) as Controller. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.